Home / Recalls / Exela Pharma Sciences LLC / D-1585-2020

D-1585-2020 Class III Terminated

Recalled by Exela Pharma Sciences LLC — Lenoir, NC

FDA drug recall D-1585-2020 was initiated by Exela Pharma Sciences LLC on May 5, 2020 and is designated Class III. Reason for recall: Short Fill The recall status is terminated (terminated Jan 14, 2022). Affected quantity: 23,775 vials.

Recall Details

Product Type: Drugs
Report Date: Sep 23, 2020
Initiation Date: May 5, 2020
Termination Date: Jan 14, 2022
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 23,775 vials

Product Description

Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) Single Dose Vials, Rx only, Manufactured By: Exela Pharma Sciences, LLC. Lenoir, NC NDC 51754-2001-4

Reason for Recall

Short Fill

Distribution Pattern

Nationwide and Puerto Rico

Code Information

Lot #P0000471, Catalog #2020TS002, Exp Date: 04/2021

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-1585-2020
openFDA file date: Nov 3, 2026
Loaded by RegDataLab: Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Exela Pharma Sciences LLC

D-0620-2025 Class II — 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For… (Jul 30, 2025)
D-0303-2025 Class II — 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL… (Mar 7, 2025)
D-0117-2024 Class I — Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL), 100 mL… (Oct 18, 2023)
D-0118-2024 Class I — ELCYS (cysteine hydrochloride injection), USP, 500 mg/10mL (50 mg/mL), 10x10 mL… (Oct 18, 2023)
D-0116-2024 Class I — 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1mEq/mL), a) 20x50 mL… (Oct 18, 2023)
D-0079-2023 Class I — 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose… (Nov 28, 2022)
D-0080-2023 Class I — 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose… (Nov 28, 2022)
D-0023-2023 Class I — 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose… (Oct 4, 2022)
D-0022-2023 Class I — 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose… (Oct 4, 2022)
D-0369-2022 Class II — 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx… (Jan 11, 2022)